nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—ESR2—uterine cancer	0.259	0.619	CbGaD
Estriol—ESR1—uterine cancer	0.159	0.381	CbGaD
Estriol—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.136	0.325	CbGbCtD
Estriol—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.0984	0.235	CbGbCtD
Estriol—SHBG—Progesterone—uterine cancer	0.0902	0.216	CbGbCtD
Estriol—ESR1—Progesterone—uterine cancer	0.0652	0.156	CbGbCtD
Estriol—ABCB1—Progesterone—uterine cancer	0.0112	0.0267	CbGbCtD
Estriol—ABCB1—Dactinomycin—uterine cancer	0.00886	0.0212	CbGbCtD
Estriol—ABCB1—Etoposide—uterine cancer	0.005	0.012	CbGbCtD
Estriol—SHBG—semen—uterine cancer	0.00464	0.153	CbGeAlD
Estriol—ESR2—oviduct—uterine cancer	0.0035	0.116	CbGeAlD
Estriol—ABCB1—Doxorubicin—uterine cancer	0.00341	0.00815	CbGbCtD
Estriol—ESR1—oviduct—uterine cancer	0.0024	0.0792	CbGeAlD
Estriol—ESR2—epithelium—uterine cancer	0.000879	0.029	CbGeAlD
Estriol—ESR2—uterine cervix—uterine cancer	0.000872	0.0288	CbGeAlD
Estriol—ESR2—smooth muscle tissue—uterine cancer	0.000847	0.028	CbGeAlD
Estriol—ESR2—renal system—uterine cancer	0.000816	0.0269	CbGeAlD
Estriol—ESR2—endometrium—uterine cancer	0.000789	0.026	CbGeAlD
Estriol—ESR1—myometrium—uterine cancer	0.000767	0.0253	CbGeAlD
Estriol—SHBG—endometrium—uterine cancer	0.000767	0.0253	CbGeAlD
Estriol—ESR2—uterus—uterine cancer	0.000727	0.024	CbGeAlD
Estriol—SHBG—uterus—uterine cancer	0.000706	0.0233	CbGeAlD
Estriol—SLCO1A2—renal system—uterine cancer	0.000659	0.0217	CbGeAlD
Estriol—ESR2—female reproductive system—uterine cancer	0.000653	0.0216	CbGeAlD
Estriol—SHBG—female reproductive system—uterine cancer	0.000635	0.021	CbGeAlD
Estriol—ESR1—epithelium—uterine cancer	0.000602	0.0199	CbGeAlD
Estriol—ESR1—uterine cervix—uterine cancer	0.000597	0.0197	CbGeAlD
Estriol—ESR2—female gonad—uterine cancer	0.000594	0.0196	CbGeAlD
Estriol—ESR2—vagina—uterine cancer	0.000591	0.0195	CbGeAlD
Estriol—ESR1—smooth muscle tissue—uterine cancer	0.00058	0.0192	CbGeAlD
Estriol—SHBG—female gonad—uterine cancer	0.000578	0.0191	CbGeAlD
Estriol—SHBG—vagina—uterine cancer	0.000574	0.019	CbGeAlD
Estriol—ESR1—decidua—uterine cancer	0.000569	0.0188	CbGeAlD
Estriol—ESR1—renal system—uterine cancer	0.000559	0.0184	CbGeAlD
Estriol—ESR1—endometrium—uterine cancer	0.00054	0.0178	CbGeAlD
Estriol—ESR1—uterus—uterine cancer	0.000498	0.0164	CbGeAlD
Estriol—ESR1—female reproductive system—uterine cancer	0.000447	0.0148	CbGeAlD
Estriol—Quinestrol—ESR1—uterine cancer	0.000442	0.126	CrCbGaD
Estriol—Estramustine—ESR2—uterine cancer	0.000441	0.126	CrCbGaD
Estriol—ESR1—female gonad—uterine cancer	0.000407	0.0134	CbGeAlD
Estriol—ESR1—vagina—uterine cancer	0.000405	0.0134	CbGeAlD
Estriol—ESR2—lymph node—uterine cancer	0.000382	0.0126	CbGeAlD
Estriol—Estropipate—ESR2—uterine cancer	0.000363	0.104	CrCbGaD
Estriol—Mestranol—ESR1—uterine cancer	0.000335	0.0957	CrCbGaD
Estriol—ABCB1—myometrium—uterine cancer	0.000303	0.01	CbGeAlD
Estriol—Estramustine—ESR1—uterine cancer	0.000272	0.0776	CrCbGaD
Estriol—ESR1—Nuclear Receptors—PGR—uterine cancer	0.000268	0.0133	CbGpPWpGaD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—ESR1—uterine cancer	0.000268	0.0132	CbGpPWpGaD
Estriol—ESR1—Nuclear signaling by ERBB4—PGR—uterine cancer	0.000263	0.013	CbGpPWpGaD
Estriol—ESR1—lymph node—uterine cancer	0.000262	0.00864	CbGeAlD
Estriol—Ethinyl Estradiol—ESR2—uterine cancer	0.000259	0.074	CrCbGaD
Estriol—ESR1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	0.000256	0.0127	CbGpPWpGaD
Estriol—SHBG—Nongenotropic Androgen signaling—AKT1—uterine cancer	0.000255	0.0126	CbGpPWpGaD
Estriol—ABCB1—epithelium—uterine cancer	0.000238	0.00786	CbGeAlD
Estriol—ESR1—Nuclear Receptors—ESR2—uterine cancer	0.000236	0.0117	CbGpPWpGaD
Estriol—ABCB1—uterine cervix—uterine cancer	0.000236	0.00779	CbGeAlD
Estriol—ESR1—LKB1 signaling events—YWHAE—uterine cancer	0.000232	0.0115	CbGpPWpGaD
Estriol—Conjugated Estrogens—ESR2—uterine cancer	0.000226	0.0647	CrCbGaD
Estriol—Estrone—ESR2—uterine cancer	0.000226	0.0645	CrCbGaD
Estriol—ABCB1—decidua—uterine cancer	0.000225	0.00742	CbGeAlD
Estriol—ESR2—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.000225	0.0111	CbGpPWpGaD
Estriol—Estropipate—ESR1—uterine cancer	0.000223	0.0638	CrCbGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—ESR2—uterine cancer	0.000222	0.011	CbGpPWpGaD
Estriol—ESR2—Ovarian Infertility Genes—CDKN1B—uterine cancer	0.000222	0.011	CbGpPWpGaD
Estriol—ABCB1—renal system—uterine cancer	0.000221	0.00729	CbGeAlD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000217	0.0107	CbGpPWpGaD
Estriol—ABCB1—endometrium—uterine cancer	0.000213	0.00704	CbGeAlD
Estriol—ESR1—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000212	0.0105	CbGpPWpGaD
Estriol—ABCB1—mammalian vulva—uterine cancer	0.000206	0.00681	CbGeAlD
Estriol—ABCB1—uterus—uterine cancer	0.000197	0.00649	CbGeAlD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000195	0.00967	CbGpPWpGaD
Estriol—ESR1—LKB1 signaling events—STK11—uterine cancer	0.000194	0.00962	CbGpPWpGaD
Estriol—Alopecia—Progesterone—uterine cancer	0.000194	0.00177	CcSEcCtD
Estriol—Mental disorder—Progesterone—uterine cancer	0.000193	0.00175	CcSEcCtD
Estriol—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.000192	0.00175	CcSEcCtD
Estriol—Malnutrition—Progesterone—uterine cancer	0.000191	0.00174	CcSEcCtD
Estriol—Polyp—Doxorubicin—uterine cancer	0.000191	0.00174	CcSEcCtD
Estriol—Flatulence—Progesterone—uterine cancer	0.000188	0.00172	CcSEcCtD
Estriol—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000188	0.00171	CcSEcCtD
Estriol—Tension—Progesterone—uterine cancer	0.000188	0.00171	CcSEcCtD
Estriol—Cyst—Epirubicin—uterine cancer	0.000188	0.00171	CcSEcCtD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—ESR1—uterine cancer	0.000187	0.00927	CbGpPWpGaD
Estriol—ESR1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000187	0.00924	CbGpPWpGaD
Estriol—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.000186	0.00169	CcSEcCtD
Estriol—Nervousness—Progesterone—uterine cancer	0.000186	0.00169	CcSEcCtD
Estriol—Back pain—Progesterone—uterine cancer	0.000185	0.00168	CcSEcCtD
Estriol—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.000185	0.00168	CcSEcCtD
Estriol—Seborrhoeic dermatitis—Epirubicin—uterine cancer	0.000184	0.00168	CcSEcCtD
Estriol—Muscle spasms—Progesterone—uterine cancer	0.000184	0.00167	CcSEcCtD
Estriol—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000181	0.00164	CcSEcCtD
Estriol—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00018	0.00164	CcSEcCtD
Estriol—Cardiac failure congestive—Etoposide—uterine cancer	0.000179	0.00163	CcSEcCtD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—PGR—uterine cancer	0.000177	0.00875	CbGpPWpGaD
Estriol—ABCB1—female reproductive system—uterine cancer	0.000177	0.00584	CbGeAlD
Estriol—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000176	0.0016	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—uterine cancer	0.000176	0.0087	CbGpPWpGaD
Estriol—Angioedema—Progesterone—uterine cancer	0.000175	0.00159	CcSEcCtD
Estriol—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.000174	0.00159	CcSEcCtD
Estriol—Cyst—Doxorubicin—uterine cancer	0.000174	0.00158	CcSEcCtD
Estriol—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.000173	0.00158	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—IRF1—uterine cancer	0.000172	0.00851	CbGpPWpGaD
Estriol—Estradiol—ESR2—uterine cancer	0.000171	0.0489	CrCbGaD
Estriol—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.000171	0.00155	CcSEcCtD
Estriol—Seborrhoeic dermatitis—Doxorubicin—uterine cancer	0.00017	0.00155	CcSEcCtD
Estriol—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00017	0.00155	CcSEcCtD
Estriol—Vaginal haemorrhage—Epirubicin—uterine cancer	0.00017	0.00154	CcSEcCtD
Estriol—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000168	0.00153	CcSEcCtD
Estriol—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.000168	0.00153	CcSEcCtD
Estriol—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000167	0.00152	CcSEcCtD
Estriol—Hypertension—Progesterone—uterine cancer	0.000165	0.0015	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.000164	0.00812	CbGpPWpGaD
Estriol—Anxiety—Progesterone—uterine cancer	0.000162	0.00148	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000162	0.00147	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—YWHAE—uterine cancer	0.000161	0.00795	CbGpPWpGaD
Estriol—ABCB1—female gonad—uterine cancer	0.000161	0.00531	CbGeAlD
Estriol—ABCB1—vagina—uterine cancer	0.00016	0.00528	CbGeAlD
Estriol—Ethinyl Estradiol—ESR1—uterine cancer	0.00016	0.0456	CrCbGaD
Estriol—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000158	0.00144	CcSEcCtD
Estriol—Vaginal haemorrhage—Doxorubicin—uterine cancer	0.000157	0.00143	CcSEcCtD
Estriol—Oedema—Progesterone—uterine cancer	0.000156	0.00142	CcSEcCtD
Estriol—Anaphylactic shock—Progesterone—uterine cancer	0.000156	0.00142	CcSEcCtD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	0.000156	0.0077	CbGpPWpGaD
Estriol—Infection—Progesterone—uterine cancer	0.000155	0.00141	CcSEcCtD
Estriol—Shock—Progesterone—uterine cancer	0.000154	0.0014	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—BIRC5—uterine cancer	0.000153	0.00758	CbGpPWpGaD
Estriol—Nervous system disorder—Progesterone—uterine cancer	0.000153	0.00139	CcSEcCtD
Estriol—Skin disorder—Progesterone—uterine cancer	0.000152	0.00138	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	0.000149	0.00739	CbGpPWpGaD
Estriol—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000147	0.00134	CcSEcCtD
Estriol—Erythema multiforme—Dactinomycin—uterine cancer	0.000147	0.00134	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000147	0.00133	CcSEcCtD
Estriol—Breast pain—Epirubicin—uterine cancer	0.000144	0.00131	CcSEcCtD
Estriol—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000141	0.00129	CcSEcCtD
Estriol—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000141	0.00129	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—SOCS3—uterine cancer	0.000141	0.00699	CbGpPWpGaD
Estriol—Insomnia—Progesterone—uterine cancer	0.000141	0.00129	CcSEcCtD
Estriol—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000141	0.00128	CcSEcCtD
Estriol—Conjugated Estrogens—ESR1—uterine cancer	0.000139	0.0398	CrCbGaD
Estriol—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.00127	CcSEcCtD
Estriol—Estrone—ESR1—uterine cancer	0.000139	0.0397	CrCbGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000139	0.00687	CbGpPWpGaD
Estriol—Bone disorder—Epirubicin—uterine cancer	0.000139	0.00126	CcSEcCtD
Estriol—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.00126	CcSEcCtD
Estriol—Dyspepsia—Progesterone—uterine cancer	0.000137	0.00125	CcSEcCtD
Estriol—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000137	0.00125	CcSEcCtD
Estriol—Alopecia—Dactinomycin—uterine cancer	0.000137	0.00125	CcSEcCtD
Estriol—Gastrointestinal disorder—Progesterone—uterine cancer	0.000135	0.00123	CcSEcCtD
Estriol—Pain—Progesterone—uterine cancer	0.000133	0.00122	CcSEcCtD
Estriol—Breast pain—Doxorubicin—uterine cancer	0.000133	0.00121	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	0.000129	0.00636	CbGpPWpGaD
Estriol—Bone disorder—Doxorubicin—uterine cancer	0.000129	0.00117	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	0.000128	0.00635	CbGpPWpGaD
Estriol—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000128	0.00116	CcSEcCtD
Estriol—Gastrointestinal pain—Progesterone—uterine cancer	0.000128	0.00116	CcSEcCtD
Estriol—Pulmonary embolism—Epirubicin—uterine cancer	0.000125	0.00114	CcSEcCtD
Estriol—Vaginal inflammation—Epirubicin—uterine cancer	0.000125	0.00114	CcSEcCtD
Estriol—Infestation—Etoposide—uterine cancer	0.000125	0.00114	CcSEcCtD
Estriol—Infestation NOS—Etoposide—uterine cancer	0.000125	0.00114	CcSEcCtD
Estriol—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000125	0.00113	CcSEcCtD
Estriol—Urticaria—Progesterone—uterine cancer	0.000124	0.00113	CcSEcCtD
Estriol—Acute coronary syndrome—Etoposide—uterine cancer	0.000123	0.00112	CcSEcCtD
Estriol—Abdominal pain—Progesterone—uterine cancer	0.000123	0.00112	CcSEcCtD
Estriol—Myocardial infarction—Etoposide—uterine cancer	0.000123	0.00112	CcSEcCtD
Estriol—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000122	0.00111	CcSEcCtD
Estriol—Fluid retention—Epirubicin—uterine cancer	0.000119	0.00108	CcSEcCtD
Estriol—Vaginal infection—Epirubicin—uterine cancer	0.000118	0.00108	CcSEcCtD
Estriol—Hepatobiliary disease—Etoposide—uterine cancer	0.000118	0.00108	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	0.000118	0.00584	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000117	0.00578	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—SOCS3—uterine cancer	0.000117	0.00577	CbGpPWpGaD
Estriol—Vaginal inflammation—Doxorubicin—uterine cancer	0.000116	0.00106	CcSEcCtD
Estriol—Pulmonary embolism—Doxorubicin—uterine cancer	0.000116	0.00106	CcSEcCtD
Estriol—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000116	0.00105	CcSEcCtD
Estriol—Cramps of lower extremities—Epirubicin—uterine cancer	0.000115	0.00105	CcSEcCtD
Estriol—Hypersensitivity—Progesterone—uterine cancer	0.000115	0.00105	CcSEcCtD
Estriol—Neoplasm—Epirubicin—uterine cancer	0.000113	0.00103	CcSEcCtD
Estriol—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000112	0.00102	CcSEcCtD
Estriol—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000112	0.00102	CcSEcCtD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	0.000112	0.00553	CbGpPWpGaD
Estriol—Pruritus—Progesterone—uterine cancer	0.00011	0.00101	CcSEcCtD
Estriol—Oedema—Dactinomycin—uterine cancer	0.00011	0.001	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—SMAD3—uterine cancer	0.00011	0.00545	CbGpPWpGaD
Estriol—Fluid retention—Doxorubicin—uterine cancer	0.00011	0.001	CcSEcCtD
Estriol—Infection—Dactinomycin—uterine cancer	0.00011	0.000998	CcSEcCtD
Estriol—Vaginal infection—Doxorubicin—uterine cancer	0.00011	0.000998	CcSEcCtD
Estriol—Abnormal vision—Epirubicin—uterine cancer	0.000109	0.000996	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	0.000109	0.00541	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000109	0.0054	CbGpPWpGaD
Estriol—Diarrhoea—Progesterone—uterine cancer	0.000107	0.000972	CcSEcCtD
Estriol—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000107	0.000971	CcSEcCtD
Estriol—Erythema multiforme—Etoposide—uterine cancer	0.000106	0.000967	CcSEcCtD
Estriol—Estradiol—ESR1—uterine cancer	0.000105	0.0301	CrCbGaD
Estriol—Thrombophlebitis—Epirubicin—uterine cancer	0.000105	0.000958	CcSEcCtD
Estriol—Eye disorder—Etoposide—uterine cancer	0.000105	0.000956	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	0.000105	0.00519	CbGpPWpGaD
Estriol—Neoplasm—Doxorubicin—uterine cancer	0.000105	0.000955	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000105	0.00519	CbGpPWpGaD
Estriol—Cardiac disorder—Etoposide—uterine cancer	0.000104	0.00095	CcSEcCtD
Estriol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000104	0.000949	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	0.000104	0.00515	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000103	0.00512	CbGpPWpGaD
Estriol—ABCB1—lymph node—uterine cancer	0.000103	0.00341	CbGeAlD
Estriol—Dizziness—Progesterone—uterine cancer	0.000103	0.00094	CcSEcCtD
Estriol—Angiopathy—Etoposide—uterine cancer	0.000102	0.000928	CcSEcCtD
Estriol—Vascular purpura—Epirubicin—uterine cancer	0.000102	0.000927	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—CDKN2A—uterine cancer	0.000102	0.00502	CbGpPWpGaD
Estriol—Immune system disorder—Etoposide—uterine cancer	0.000102	0.000924	CcSEcCtD
Estriol—Abnormal vision—Doxorubicin—uterine cancer	0.000101	0.000922	CcSEcCtD
Estriol—Cardiac failure congestive—Epirubicin—uterine cancer	0.0001	0.000914	CcSEcCtD
Estriol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0001	0.000911	CcSEcCtD
Estriol—Alopecia—Etoposide—uterine cancer	9.93e-05	0.000904	CcSEcCtD
Estriol—Vomiting—Progesterone—uterine cancer	9.93e-05	0.000903	CcSEcCtD
Estriol—ESR2—Gene Expression—PHF1—uterine cancer	9.86e-05	0.00488	CbGpPWpGaD
Estriol—Rash—Progesterone—uterine cancer	9.84e-05	0.000896	CcSEcCtD
Estriol—Dermatitis—Progesterone—uterine cancer	9.83e-05	0.000895	CcSEcCtD
Estriol—Headache—Progesterone—uterine cancer	9.78e-05	0.00089	CcSEcCtD
Estriol—Thrombophlebitis—Doxorubicin—uterine cancer	9.74e-05	0.000886	CcSEcCtD
Estriol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	9.68e-05	0.000881	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	9.65e-05	0.00477	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	9.59e-05	0.00474	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.56e-05	0.00473	CbGpPWpGaD
Estriol—Back pain—Etoposide—uterine cancer	9.47e-05	0.000862	CcSEcCtD
Estriol—ESR1—Estrogen signaling pathway—PIK3CA—uterine cancer	9.46e-05	0.00468	CbGpPWpGaD
Estriol—Pain—Dactinomycin—uterine cancer	9.44e-05	0.000859	CcSEcCtD
Estriol—Vascular purpura—Doxorubicin—uterine cancer	9.42e-05	0.000857	CcSEcCtD
Estriol—Muscle spasms—Etoposide—uterine cancer	9.41e-05	0.000856	CcSEcCtD
Estriol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	9.35e-05	0.000851	CcSEcCtD
Estriol—Cerebrovascular accident—Epirubicin—uterine cancer	9.29e-05	0.000846	CcSEcCtD
Estriol—Cardiac failure congestive—Doxorubicin—uterine cancer	9.29e-05	0.000846	CcSEcCtD
Estriol—Nausea—Progesterone—uterine cancer	9.27e-05	0.000844	CcSEcCtD
Estriol—Gastrointestinal pain—Dactinomycin—uterine cancer	9.02e-05	0.000821	CcSEcCtD
Estriol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	8.99e-05	0.000819	CcSEcCtD
Estriol—Migraine—Epirubicin—uterine cancer	8.96e-05	0.000816	CcSEcCtD
Estriol—Rash—Medroxyprogesterone Acetate—uterine cancer	8.92e-05	0.000812	CcSEcCtD
Estriol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	8.91e-05	0.000811	CcSEcCtD
Estriol—Headache—Medroxyprogesterone Acetate—uterine cancer	8.86e-05	0.000807	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—PGR—uterine cancer	8.86e-05	0.00438	CbGpPWpGaD
Estriol—Abdominal pain—Dactinomycin—uterine cancer	8.72e-05	0.000794	CcSEcCtD
Estriol—ESR1—FOXA1 transcription factor network—CDKN1B—uterine cancer	8.67e-05	0.00429	CbGpPWpGaD
Estriol—Cerebrovascular accident—Doxorubicin—uterine cancer	8.6e-05	0.000783	CcSEcCtD
Estriol—Hypertension—Etoposide—uterine cancer	8.45e-05	0.000769	CcSEcCtD
Estriol—Nausea—Medroxyprogesterone Acetate—uterine cancer	8.4e-05	0.000765	CcSEcCtD
Estriol—ESR2—Gene Expression—CHD4—uterine cancer	8.38e-05	0.00415	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	8.36e-05	0.00414	CbGpPWpGaD
Estriol—Migraine—Doxorubicin—uterine cancer	8.3e-05	0.000755	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	8.27e-05	0.000753	CcSEcCtD
Estriol—Breast disorder—Epirubicin—uterine cancer	8.23e-05	0.000749	CcSEcCtD
Estriol—Hypersensitivity—Dactinomycin—uterine cancer	8.13e-05	0.00074	CcSEcCtD
Estriol—Anaphylactic shock—Etoposide—uterine cancer	7.99e-05	0.000727	CcSEcCtD
Estriol—Infection—Etoposide—uterine cancer	7.93e-05	0.000722	CcSEcCtD
Estriol—Abdominal distension—Epirubicin—uterine cancer	7.92e-05	0.000721	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—EP300—uterine cancer	7.9e-05	0.00391	CbGpPWpGaD
Estriol—Asthma—Epirubicin—uterine cancer	7.87e-05	0.000717	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	7.81e-05	0.00386	CbGpPWpGaD
Estriol—Skin disorder—Etoposide—uterine cancer	7.76e-05	0.000706	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—CCL2—uterine cancer	7.74e-05	0.00383	CbGpPWpGaD
Estriol—ESR1—Estrogen signaling pathway—AKT1—uterine cancer	7.73e-05	0.00382	CbGpPWpGaD
Estriol—Breast disorder—Doxorubicin—uterine cancer	7.62e-05	0.000693	CcSEcCtD
Estriol—ESR1—FOXA1 transcription factor network—EP300—uterine cancer	7.61e-05	0.00376	CbGpPWpGaD
Estriol—Diarrhoea—Dactinomycin—uterine cancer	7.55e-05	0.000687	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	7.53e-05	0.00373	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	7.34e-05	0.00363	CbGpPWpGaD
Estriol—Abdominal distension—Doxorubicin—uterine cancer	7.33e-05	0.000667	CcSEcCtD
Estriol—Asthma—Doxorubicin—uterine cancer	7.28e-05	0.000663	CcSEcCtD
Estriol—ESR2—Generic Transcription Pathway—PGR—uterine cancer	7.27e-05	0.00359	CbGpPWpGaD
Estriol—Weight increased—Epirubicin—uterine cancer	7.16e-05	0.000652	CcSEcCtD
Estriol—Weight decreased—Epirubicin—uterine cancer	7.12e-05	0.000648	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—STK11—uterine cancer	7.12e-05	0.00352	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	7.12e-05	0.00352	CbGpPWpGaD
Estriol—ESR2—Gene Expression—SUZ12—uterine cancer	7.03e-05	0.00348	CbGpPWpGaD
Estriol—Infestation NOS—Epirubicin—uterine cancer	7.02e-05	0.000639	CcSEcCtD
Estriol—Infestation—Epirubicin—uterine cancer	7.02e-05	0.000639	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—CXCL8—uterine cancer	7.02e-05	0.00347	CbGpPWpGaD
Estriol—Vomiting—Dactinomycin—uterine cancer	7.02e-05	0.000639	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	7.01e-05	0.00347	CbGpPWpGaD
Estriol—Rash—Dactinomycin—uterine cancer	6.96e-05	0.000633	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	6.96e-05	0.00344	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.91e-05	0.00342	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.91e-05	0.00342	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Etoposide—uterine cancer	6.89e-05	0.000628	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	6.87e-05	0.0034	CbGpPWpGaD
Estriol—Pain—Etoposide—uterine cancer	6.83e-05	0.000622	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—CDKN2A—uterine cancer	6.75e-05	0.00334	CbGpPWpGaD
Estriol—Hepatobiliary disease—Epirubicin—uterine cancer	6.64e-05	0.000604	CcSEcCtD
Estriol—Weight increased—Doxorubicin—uterine cancer	6.63e-05	0.000603	CcSEcCtD
Estriol—Weight decreased—Doxorubicin—uterine cancer	6.59e-05	0.0006	CcSEcCtD
Estriol—SLCO1A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.57e-05	0.00325	CbGpPWpGaD
Estriol—Nausea—Dactinomycin—uterine cancer	6.55e-05	0.000597	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	6.54e-05	0.00323	CbGpPWpGaD
Estriol—Gastrointestinal pain—Etoposide—uterine cancer	6.53e-05	0.000594	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	6.5e-05	0.00321	CbGpPWpGaD
Estriol—Infestation NOS—Doxorubicin—uterine cancer	6.49e-05	0.000591	CcSEcCtD
Estriol—Infestation—Doxorubicin—uterine cancer	6.49e-05	0.000591	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	6.48e-05	0.00321	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—CXCL8—uterine cancer	6.39e-05	0.00316	CbGpPWpGaD
Estriol—Urticaria—Etoposide—uterine cancer	6.34e-05	0.000577	CcSEcCtD
Estriol—Abdominal pain—Etoposide—uterine cancer	6.31e-05	0.000575	CcSEcCtD
Estriol—Oedema peripheral—Epirubicin—uterine cancer	6.21e-05	0.000565	CcSEcCtD
Estriol—Connective tissue disorder—Epirubicin—uterine cancer	6.19e-05	0.000564	CcSEcCtD
Estriol—Hepatobiliary disease—Doxorubicin—uterine cancer	6.14e-05	0.000559	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—CXCL8—uterine cancer	6.12e-05	0.00303	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—CDKN1B—uterine cancer	6.12e-05	0.00303	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—ERBB2—uterine cancer	6.11e-05	0.00302	CbGpPWpGaD
Estriol—Visual impairment—Epirubicin—uterine cancer	6.07e-05	0.000553	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—EP300—uterine cancer	6.02e-05	0.00298	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—CDKN1B—uterine cancer	5.98e-05	0.00296	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	5.98e-05	0.00296	CbGpPWpGaD
Estriol—Erythema multiforme—Epirubicin—uterine cancer	5.96e-05	0.000542	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	5.96e-05	0.00295	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	5.91e-05	0.00292	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	5.9e-05	0.00292	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	5.9e-05	0.00292	CbGpPWpGaD
Estriol—Eye disorder—Epirubicin—uterine cancer	5.89e-05	0.000536	CcSEcCtD
Estriol—Hypersensitivity—Etoposide—uterine cancer	5.88e-05	0.000536	CcSEcCtD
Estriol—Cardiac disorder—Epirubicin—uterine cancer	5.85e-05	0.000532	CcSEcCtD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	5.78e-05	0.00286	CbGpPWpGaD
Estriol—Oedema peripheral—Doxorubicin—uterine cancer	5.74e-05	0.000523	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	5.73e-05	0.00284	CbGpPWpGaD
Estriol—Connective tissue disorder—Doxorubicin—uterine cancer	5.73e-05	0.000521	CcSEcCtD
Estriol—Angiopathy—Epirubicin—uterine cancer	5.72e-05	0.00052	CcSEcCtD
Estriol—Immune system disorder—Epirubicin—uterine cancer	5.69e-05	0.000518	CcSEcCtD
Estriol—Pruritus—Etoposide—uterine cancer	5.65e-05	0.000514	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—CTNNB1—uterine cancer	5.65e-05	0.00279	CbGpPWpGaD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	5.64e-05	0.00279	CbGpPWpGaD
Estriol—Visual impairment—Doxorubicin—uterine cancer	5.62e-05	0.000511	CcSEcCtD
Estriol—Alopecia—Epirubicin—uterine cancer	5.57e-05	0.000507	CcSEcCtD
Estriol—ESR1—LKB1 signaling events—TP53—uterine cancer	5.55e-05	0.00274	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—FGFR2—uterine cancer	5.53e-05	0.00273	CbGpPWpGaD
Estriol—Mental disorder—Epirubicin—uterine cancer	5.52e-05	0.000502	CcSEcCtD
Estriol—Erythema multiforme—Doxorubicin—uterine cancer	5.51e-05	0.000502	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	5.51e-05	0.00273	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—PTEN—uterine cancer	5.5e-05	0.00272	CbGpPWpGaD
Estriol—Malnutrition—Epirubicin—uterine cancer	5.49e-05	0.000499	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—EP300—uterine cancer	5.48e-05	0.00271	CbGpPWpGaD
Estriol—Diarrhoea—Etoposide—uterine cancer	5.46e-05	0.000497	CcSEcCtD
Estriol—Eye disorder—Doxorubicin—uterine cancer	5.45e-05	0.000496	CcSEcCtD
Estriol—Cardiac disorder—Doxorubicin—uterine cancer	5.41e-05	0.000492	CcSEcCtD
Estriol—Flatulence—Epirubicin—uterine cancer	5.4e-05	0.000492	CcSEcCtD
Estriol—Tension—Epirubicin—uterine cancer	5.38e-05	0.00049	CcSEcCtD
Estriol—Nervousness—Epirubicin—uterine cancer	5.33e-05	0.000485	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	5.31e-05	0.00263	CbGpPWpGaD
Estriol—Back pain—Epirubicin—uterine cancer	5.31e-05	0.000483	CcSEcCtD
Estriol—Angiopathy—Doxorubicin—uterine cancer	5.29e-05	0.000481	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	5.29e-05	0.00261	CbGpPWpGaD
Estriol—Dizziness—Etoposide—uterine cancer	5.28e-05	0.000481	CcSEcCtD
Estriol—Muscle spasms—Epirubicin—uterine cancer	5.27e-05	0.00048	CcSEcCtD
Estriol—Immune system disorder—Doxorubicin—uterine cancer	5.27e-05	0.000479	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—EP300—uterine cancer	5.25e-05	0.0026	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—CDKN2B—uterine cancer	5.21e-05	0.00258	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—VEGFA—uterine cancer	5.19e-05	0.00257	CbGpPWpGaD
Estriol—Alopecia—Doxorubicin—uterine cancer	5.15e-05	0.000469	CcSEcCtD
Estriol—Mental disorder—Doxorubicin—uterine cancer	5.11e-05	0.000465	CcSEcCtD
Estriol—Vomiting—Etoposide—uterine cancer	5.08e-05	0.000462	CcSEcCtD
Estriol—Malnutrition—Doxorubicin—uterine cancer	5.08e-05	0.000462	CcSEcCtD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.08e-05	0.00251	CbGpPWpGaD
Estriol—Rash—Etoposide—uterine cancer	5.04e-05	0.000458	CcSEcCtD
Estriol—Dermatitis—Etoposide—uterine cancer	5.03e-05	0.000458	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	5.03e-05	0.00249	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	5.02e-05	0.00248	CbGpPWpGaD
Estriol—Headache—Etoposide—uterine cancer	5e-05	0.000455	CcSEcCtD
Estriol—Flatulence—Doxorubicin—uterine cancer	5e-05	0.000455	CcSEcCtD
Estriol—Tension—Doxorubicin—uterine cancer	4.98e-05	0.000453	CcSEcCtD
Estriol—ESR1—Gene Expression—PHF1—uterine cancer	4.97e-05	0.00246	CbGpPWpGaD
Estriol—Nervousness—Doxorubicin—uterine cancer	4.93e-05	0.000449	CcSEcCtD
Estriol—Back pain—Doxorubicin—uterine cancer	4.91e-05	0.000447	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.89e-05	0.00242	CbGpPWpGaD
Estriol—Muscle spasms—Doxorubicin—uterine cancer	4.88e-05	0.000444	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	4.87e-05	0.00241	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—SMAD3—uterine cancer	4.76e-05	0.00235	CbGpPWpGaD
Estriol—Nausea—Etoposide—uterine cancer	4.74e-05	0.000432	CcSEcCtD
Estriol—Hypertension—Epirubicin—uterine cancer	4.74e-05	0.000431	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	4.67e-05	0.00231	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.66e-05	0.00231	CbGpPWpGaD
Estriol—Anxiety—Epirubicin—uterine cancer	4.65e-05	0.000424	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	4.64e-05	0.000422	CcSEcCtD
Estriol—Oedema—Epirubicin—uterine cancer	4.48e-05	0.000407	CcSEcCtD
Estriol—Anaphylactic shock—Epirubicin—uterine cancer	4.48e-05	0.000407	CcSEcCtD
Estriol—Infection—Epirubicin—uterine cancer	4.45e-05	0.000405	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.42e-05	0.00218	CbGpPWpGaD
Estriol—Shock—Epirubicin—uterine cancer	4.4e-05	0.000401	CcSEcCtD
Estriol—Nervous system disorder—Epirubicin—uterine cancer	4.39e-05	0.0004	CcSEcCtD
Estriol—Hypertension—Doxorubicin—uterine cancer	4.38e-05	0.000399	CcSEcCtD
Estriol—Skin disorder—Epirubicin—uterine cancer	4.35e-05	0.000396	CcSEcCtD
Estriol—Anxiety—Doxorubicin—uterine cancer	4.31e-05	0.000392	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	4.29e-05	0.000391	CcSEcCtD
Estriol—SLCO1A2—Metabolism—NDUFB11—uterine cancer	4.26e-05	0.00211	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—SRD5A2—uterine cancer	4.26e-05	0.00211	CbGpPWpGaD
Estriol—ESR1—Gene Expression—CHD4—uterine cancer	4.23e-05	0.00209	CbGpPWpGaD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	4.21e-05	0.00208	CbGpPWpGaD
Estriol—Oedema—Doxorubicin—uterine cancer	4.14e-05	0.000377	CcSEcCtD
Estriol—Anaphylactic shock—Doxorubicin—uterine cancer	4.14e-05	0.000377	CcSEcCtD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.14e-05	0.00205	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	4.14e-05	0.00205	CbGpPWpGaD
Estriol—Infection—Doxorubicin—uterine cancer	4.11e-05	0.000375	CcSEcCtD
Estriol—Shock—Doxorubicin—uterine cancer	4.08e-05	0.000371	CcSEcCtD
Estriol—Nervous system disorder—Doxorubicin—uterine cancer	4.06e-05	0.00037	CcSEcCtD
Estriol—Insomnia—Epirubicin—uterine cancer	4.05e-05	0.000369	CcSEcCtD
Estriol—Skin disorder—Doxorubicin—uterine cancer	4.02e-05	0.000366	CcSEcCtD
Estriol—Dyspepsia—Epirubicin—uterine cancer	3.94e-05	0.000359	CcSEcCtD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.91e-05	0.00193	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—ESR1—uterine cancer	3.88e-05	0.00192	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Epirubicin—uterine cancer	3.86e-05	0.000352	CcSEcCtD
Estriol—Pain—Epirubicin—uterine cancer	3.83e-05	0.000348	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—TP53—uterine cancer	3.76e-05	0.00186	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.75e-05	0.00186	CbGpPWpGaD
Estriol—Insomnia—Doxorubicin—uterine cancer	3.75e-05	0.000341	CcSEcCtD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	3.71e-05	0.00183	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—PGR—uterine cancer	3.66e-05	0.00181	CbGpPWpGaD
Estriol—Gastrointestinal pain—Epirubicin—uterine cancer	3.66e-05	0.000333	CcSEcCtD
Estriol—Dyspepsia—Doxorubicin—uterine cancer	3.65e-05	0.000332	CcSEcCtD
Estriol—Gastrointestinal disorder—Doxorubicin—uterine cancer	3.58e-05	0.000325	CcSEcCtD
Estriol—Urticaria—Epirubicin—uterine cancer	3.56e-05	0.000324	CcSEcCtD
Estriol—ESR1—Gene Expression—SUZ12—uterine cancer	3.54e-05	0.00175	CbGpPWpGaD
Estriol—Pain—Doxorubicin—uterine cancer	3.54e-05	0.000322	CcSEcCtD
Estriol—Abdominal pain—Epirubicin—uterine cancer	3.54e-05	0.000322	CcSEcCtD
Estriol—ESR2—Gene Expression—PGR—uterine cancer	3.5e-05	0.00173	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—ERBB2—uterine cancer	3.47e-05	0.00172	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.45e-05	0.00171	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	3.44e-05	0.0017	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—HRAS—uterine cancer	3.4e-05	0.00168	CbGpPWpGaD
Estriol—Gastrointestinal pain—Doxorubicin—uterine cancer	3.39e-05	0.000308	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.34e-05	0.00165	CbGpPWpGaD
Estriol—ESR2—Gene Expression—EZH2—uterine cancer	3.32e-05	0.00164	CbGpPWpGaD
Estriol—Hypersensitivity—Epirubicin—uterine cancer	3.3e-05	0.0003	CcSEcCtD
Estriol—Urticaria—Doxorubicin—uterine cancer	3.29e-05	0.0003	CcSEcCtD
Estriol—Abdominal pain—Doxorubicin—uterine cancer	3.27e-05	0.000298	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—AKT1—uterine cancer	3.25e-05	0.00161	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—ESR2—uterine cancer	3.23e-05	0.0016	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—CDKN1B—uterine cancer	3.21e-05	0.00159	CbGpPWpGaD
Estriol—Pruritus—Epirubicin—uterine cancer	3.17e-05	0.000288	CcSEcCtD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	3.12e-05	0.00154	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—AKR1B1—uterine cancer	3.08e-05	0.00152	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—STAR—uterine cancer	3.08e-05	0.00152	CbGpPWpGaD
Estriol—Diarrhoea—Epirubicin—uterine cancer	3.06e-05	0.000279	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	3.05e-05	0.00151	CbGpPWpGaD
Estriol—Hypersensitivity—Doxorubicin—uterine cancer	3.05e-05	0.000278	CcSEcCtD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.04e-05	0.00151	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—AKT1—uterine cancer	3e-05	0.00148	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.98e-05	0.00147	CbGpPWpGaD
Estriol—Dizziness—Epirubicin—uterine cancer	2.96e-05	0.000269	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—PTEN—uterine cancer	2.96e-05	0.00146	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—CXCL8—uterine cancer	2.94e-05	0.00145	CbGpPWpGaD
Estriol—Pruritus—Doxorubicin—uterine cancer	2.93e-05	0.000267	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	2.91e-05	0.00144	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.89e-05	0.00143	CbGpPWpGaD
Estriol—Vomiting—Epirubicin—uterine cancer	2.85e-05	0.000259	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.84e-05	0.0014	CbGpPWpGaD
Estriol—Diarrhoea—Doxorubicin—uterine cancer	2.83e-05	0.000258	CcSEcCtD
Estriol—Rash—Epirubicin—uterine cancer	2.82e-05	0.000257	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.82e-05	0.0014	CbGpPWpGaD
Estriol—Dermatitis—Epirubicin—uterine cancer	2.82e-05	0.000257	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.82e-05	0.00139	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.81e-05	0.00139	CbGpPWpGaD
Estriol—Headache—Epirubicin—uterine cancer	2.8e-05	0.000255	CcSEcCtD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.8e-05	0.00138	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.76e-05	0.00136	CbGpPWpGaD
Estriol—Dizziness—Doxorubicin—uterine cancer	2.74e-05	0.000249	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.69e-05	0.00133	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.68e-05	0.00132	CbGpPWpGaD
Estriol—Nausea—Epirubicin—uterine cancer	2.66e-05	0.000242	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—NRAS—uterine cancer	2.64e-05	0.00131	CbGpPWpGaD
Estriol—Vomiting—Doxorubicin—uterine cancer	2.63e-05	0.00024	CcSEcCtD
Estriol—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	2.63e-05	0.0013	CbGpPWpGaD
Estriol—Rash—Doxorubicin—uterine cancer	2.61e-05	0.000238	CcSEcCtD
Estriol—Dermatitis—Doxorubicin—uterine cancer	2.61e-05	0.000237	CcSEcCtD
Estriol—Headache—Doxorubicin—uterine cancer	2.59e-05	0.000236	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.53e-05	0.00125	CbGpPWpGaD
Estriol—ESR2—Gene Expression—CDKN2B—uterine cancer	2.51e-05	0.00124	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.47e-05	0.00122	CbGpPWpGaD
Estriol—Nausea—Doxorubicin—uterine cancer	2.46e-05	0.000224	CcSEcCtD
Estriol—SLCO1A2—Metabolism—POLD1—uterine cancer	2.42e-05	0.0012	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	2.4e-05	0.00119	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.39e-05	0.00118	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.35e-05	0.00116	CbGpPWpGaD
Estriol—ESR2—Gene Expression—SMAD3—uterine cancer	2.29e-05	0.00113	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	2.28e-05	0.00113	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—KRAS—uterine cancer	2.27e-05	0.00112	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—AKR1C1—uterine cancer	2.26e-05	0.00112	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AKR1B10—uterine cancer	2.24e-05	0.00111	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.23e-05	0.0011	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	2.09e-05	0.00103	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.08e-05	0.00103	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	2.03e-05	0.001	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—RRM2—uterine cancer	2.01e-05	0.000996	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—DCN—uterine cancer	1.96e-05	0.000967	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—HRAS—uterine cancer	1.93e-05	0.000955	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.89e-05	0.000936	CbGpPWpGaD
Estriol—ESR2—Gene Expression—ESR1—uterine cancer	1.87e-05	0.000924	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—RNF43—uterine cancer	1.86e-05	0.000918	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CYP11A1—uterine cancer	1.84e-05	0.000911	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NDUFB11—uterine cancer	1.82e-05	0.000902	CbGpPWpGaD
Estriol—ABCB1—Metabolism—SRD5A2—uterine cancer	1.82e-05	0.000902	CbGpPWpGaD
Estriol—ESR1—Gene Expression—PGR—uterine cancer	1.76e-05	0.000873	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.76e-05	0.00087	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—AKR1C3—uterine cancer	1.74e-05	0.000861	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.74e-05	0.00086	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.71e-05	0.000848	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—AKT1—uterine cancer	1.71e-05	0.000844	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—INHBA—uterine cancer	1.7e-05	0.00084	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.68e-05	0.000832	CbGpPWpGaD
Estriol—ESR1—Gene Expression—EZH2—uterine cancer	1.68e-05	0.000829	CbGpPWpGaD
Estriol—ESR1—Gene Expression—ESR2—uterine cancer	1.55e-05	0.000768	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.53e-05	0.000757	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AKR1C1—uterine cancer	1.53e-05	0.000756	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.42e-05	0.000703	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.42e-05	0.000701	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—STK11—uterine cancer	1.36e-05	0.00067	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CYP19A1—uterine cancer	1.36e-05	0.00067	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.34e-05	0.000662	CbGpPWpGaD
Estriol—ABCB1—Metabolism—AKR1B1—uterine cancer	1.32e-05	0.000652	CbGpPWpGaD
Estriol—ABCB1—Metabolism—STAR—uterine cancer	1.32e-05	0.000652	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.3e-05	0.000645	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.27e-05	0.000629	CbGpPWpGaD
Estriol—ESR1—Gene Expression—CDKN2B—uterine cancer	1.26e-05	0.000625	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.24e-05	0.000615	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.21e-05	0.0006	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.18e-05	0.000583	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AKR1C3—uterine cancer	1.18e-05	0.000582	CbGpPWpGaD
Estriol—ESR1—Gene Expression—SMAD3—uterine cancer	1.15e-05	0.000571	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PGR—uterine cancer	1.15e-05	0.000567	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—YWHAE—uterine cancer	1.09e-05	0.000541	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—FBXW7—uterine cancer	1.05e-05	0.000519	CbGpPWpGaD
Estriol—ABCB1—Metabolism—POLD1—uterine cancer	1.03e-05	0.000512	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—MTHFR—uterine cancer	1.02e-05	0.000504	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1e-05	0.000495	CbGpPWpGaD
Estriol—ABCB1—Metabolism—AKR1C1—uterine cancer	9.68e-06	0.000479	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	9.2e-06	0.000455	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—STK11—uterine cancer	9.17e-06	0.000454	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.98e-06	0.000444	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.9e-06	0.00044	CbGpPWpGaD
Estriol—ABCB1—Metabolism—RRM2—uterine cancer	8.62e-06	0.000427	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—SOCS3—uterine cancer	8.59e-06	0.000425	CbGpPWpGaD
Estriol—ABCB1—Metabolism—DCN—uterine cancer	8.37e-06	0.000414	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CDKN2B—uterine cancer	8.22e-06	0.000407	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IGF1R—uterine cancer	7.98e-06	0.000395	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CYP11A1—uterine cancer	7.89e-06	0.00039	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.52e-06	0.000372	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—SMAD3—uterine cancer	7.51e-06	0.000371	CbGpPWpGaD
Estriol—ABCB1—Metabolism—AKR1C3—uterine cancer	7.45e-06	0.000368	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—FGFR2—uterine cancer	7.16e-06	0.000354	CbGpPWpGaD
Estriol—ESR2—Gene Expression—AKT1—uterine cancer	6.74e-06	0.000333	CbGpPWpGaD
Estriol—ABCB1—Metabolism—STK11—uterine cancer	5.8e-06	0.000287	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CYP19A1—uterine cancer	5.8e-06	0.000287	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PTEN—uterine cancer	5.67e-06	0.00028	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—EP300—uterine cancer	5.4e-06	0.000267	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CCL2—uterine cancer	5.39e-06	0.000267	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—ERBB2—uterine cancer	4.5e-06	0.000222	CbGpPWpGaD
Estriol—ABCB1—Metabolism—MTHFR—uterine cancer	4.36e-06	0.000216	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CXCL8—uterine cancer	4.26e-06	0.000211	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CDKN1B—uterine cancer	4.16e-06	0.000206	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PIK3CA—uterine cancer	4e-06	0.000198	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CTNNB1—uterine cancer	3.93e-06	0.000195	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PTEN—uterine cancer	3.83e-06	0.00019	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—EP300—uterine cancer	3.66e-06	0.000181	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—VEGFA—uterine cancer	3.46e-06	0.000171	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NRAS—uterine cancer	3.42e-06	0.000169	CbGpPWpGaD
Estriol—ESR1—Gene Expression—AKT1—uterine cancer	3.4e-06	0.000168	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—AKT1—uterine cancer	3.27e-06	0.000162	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KRAS—uterine cancer	2.94e-06	0.000146	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PIK3CA—uterine cancer	2.7e-06	0.000134	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TP53—uterine cancer	2.62e-06	0.000129	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—HRAS—uterine cancer	2.5e-06	0.000124	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PTEN—uterine cancer	2.43e-06	0.00012	CbGpPWpGaD
Estriol—ABCB1—Metabolism—EP300—uterine cancer	2.31e-06	0.000114	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AKT1—uterine cancer	2.21e-06	0.000109	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PIK3CA—uterine cancer	1.71e-06	8.46e-05	CbGpPWpGaD
Estriol—ABCB1—Metabolism—AKT1—uterine cancer	1.4e-06	6.91e-05	CbGpPWpGaD
